ANTHONY J BRANDAU
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology EAST LANSING, MI NPI 1346560182
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MI NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$7,967.80
- Category: General Payments
- Program years: PY2018–2024
- Record count: 409
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,188.91 across 61 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,188.91 | 61 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $169.61 | 9 |
| Merck Sharp & Dohme Corporation | $169.37 | 7 |
| Acerta Pharma LLC | $137.28 | 7 |
| Genentech USA, Inc. | $134.80 | 9 |
| Janssen Biotech, Inc. | $87.12 | 4 |
| Celgene Corporation | $77.57 | 3 |
| SpringWorks Therapeutics, Inc. | $43.69 | 2 |
| EISAI INC. | $38.43 | 2 |
| GlaxoSmithKline, LLC. | $37.31 | 2 |
| PFIZER INC. | $36.16 | 2 |
| Dendreon Pharmaceuticals LLC | $28.31 | 1 |
| Sumitomo Pharma America, Inc. | $23.62 | 1 |
| TAIHO ONCOLOGY, INC. | $23.30 | 1 |
| Rigel Pharmaceuticals, Inc. | $21.71 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.32 | 1 |
| Spectrum Pharmaceuticals Inc. | $18.98 | 1 |
| Mirati Therapeutics, Inc. | $17.91 | 1 |
| ARRAY BIOPHARMA INC | $16.33 | 1 |
| TerSera Therapeutics LLC | $16.23 | 1 |
| ABBVIE INC. | $15.54 | 1 |
| Lilly USA, LLC | $15.14 | 1 |
| Stemline Therapeutics Inc. | $13.62 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $13.43 | 1 |
| Kite Pharma, Inc. | $13.13 | 1 |
By program year
Records — PY2024 (61)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.